BioLargo, Inc. (OTCQB:BLGO) invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control.
Monday, 5 August 2019
Dennis Calvert, CEO of BioLargo Inc. Joins the Stock Day Podcast to Discuss New Contracts and Federal Grants
Phoenix, Arizona--(Newsfile Corp. - August 5, 2019) - The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO) ("the Company"), an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. BioLargo President and CEO Dennis P. Calvert joined Stock Day host Everett Jolly for an audio interview.
Jolly started by inquiring about BioLargo Engineering's recently announced subcontracts with the US Air Force, which the Company secured as part of a "teaming agreement" with Bhate Environmental Associates (disclosed in a press release here). Calvert explained that the government looks for qualified environmental engineering teams to provide monitoring, compliance, and maintenance to military bases. Applicants must meet strict qualifications in terms of finances, talent, and capability. Upon meeting these standards, the Company was chosen as a subcontractor to provide air quality services to several USAF locations. "It's a great development," stated Calvert.
Jolly then asked about the Company's AOS platform. Calvert explained that BioLargo offers a full-service solution by combining the engineering, infrastructure, installation, and service components of the water treatment process. "We have a special piece of technology in the AOS that allows us to take soluble organic contaminants and remove them from the water stream in a way that's never been done before," explained Calvert. He further explained that the Company just received financial support from (The National Research Council of Canada - Industrial Research Assistance Program, "NRC-IPRAP") to deploy the AOS in a demonstration pilot in Southern California to treat captured storm water.
To close the interview, Calvert shared that BioLargo's technologies would not have been possible without the patience and support of its investors. Calvert noted that the future of BioLargo will revolve around scalability and execution surrounding its technologies. "The future to us is really unlimited," he stated. "It's all about getting the right people, making sure the capital is in place, and then seeing these solutions go out to make the world a better place," he closed.
BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.
Dennis Calvert President and CEO BioLargo, Inc. 949-643-9540 x2
Safe Harbor Act
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
About The "Stock Day" Podcast
Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America. Stock Day recently launched its Video Interview Studio located in Phoenix, Arizona.